Patients diagnosed with early-stage diabetic kidney disease saw measurable improvements in long-term health outcomes after using the KidneyIntelX risk assessment tool. A two-year study of 2,470 patients across two major U.S. health systems confirms that biomarker-guided treatment significantly slows disease progression and shifts patients into lower risk categories.
Accounting software provider Netgain has launched an open beta for its latest consolidation platform, inviting a founding cohort of industry leaders to refine the product before its 2027 commercial debut. The initiative aims to replace manual spreadsheet workflows in organizations managing complex, multi-entity ownership structures.
The voting landscape at AB Volvo shifted on June 30, 2026, as 151 Series A shares were converted into an equal number of Series B shares. This routine adjustment, facilitated by provisions established during the 2011 Annual General Meeting, alters the company’s internal distribution of voting power.
ADC Therapeutics has finished enrolling 100 patients for its LOTIS-7 Phase 1b trial, which tests the combination of ZYNLONTA and the bispecific antibody glofitamab in treating relapsed or refractory diffuse large B-cell lymphoma. The company plans to release full clinical data from the study by the end of 2026.
Saudi Arabia’s Al Rajhi Capital has partnered with Detroit-based financial news provider Benzinga to overhaul its U.S. equities platform. By embedding real-time intelligence directly into its digital ecosystem, the firm aims to provide regional investors with the same depth of market data typically reserved for global institutional players.
Corporate demand for professional pet relocation services has surged nearly 300% over the last five years, forcing companies to overhaul their mobility policies. With nearly half of all firms now providing some form of pet shipment support, what was once a fringe perk is becoming a critical tool for talent retention.
A $4.5 million investment from the CD&R Foundation will support five New York City non-profit organizations over the next four years. The grant package aims to remove barriers to employment and foster economic mobility through specialized local programs, marking a significant expansion of the firm’s ongoing community development efforts.
To combat the unpredictability of drug development, Allucent has launched IGNITE, a global network of over 250 pre-qualified clinical research sites. By shifting from ad-hoc site selection to long-term partnerships, the CRO aims to accelerate trial activation and patient enrollment for small and mid-sized biopharma firms.
Michel Detheux, the former head of iTeos Therapeutics, has been named CEO of Muna Therapeutics, effective June 29, 2026. He succeeds founding CEO Rita Balice-Gordon, who transitions to the company’s Board of Directors after guiding the firm through its evolution into a clinical-stage developer of neurodegenerative therapies.
Toronto-based Quarterhill Inc. has entered a definitive agreement to acquire the tolling solutions business of Conduent Business Services, a move set to triple the company’s tolling revenue. The acquisition, valued at $70 million in cash plus a 7% equity stake, aims to consolidate the firm's position in the global ITS market.
Houston-based Main Street Capital Corporation has secured a significant boost to its financial flexibility, raising its total corporate credit facility commitments to $1.24 billion. The amendment, finalized on June 30, 2026, also pushes the firm’s debt maturity schedule out by an additional year to June 2031.
Otis Worldwide Corporation is expanding its Gen3 MOD elevator modernization platform into Europe, the Middle East, and Africa. Aimed at updating aging infrastructure, the initiative allows building owners to transition legacy rope-based systems to the company’s signature coated steel belt technology, prioritizing safety compliance and enhanced passenger connectivity.
Shareholders of Lufax Holding Ltd gathered in Shanghai on June 30, 2026, to solidify the company's governance structure, formally approving two years of consolidated financial statements and finalizing the re-election of ten key members to the board of directors.
A randomized, double-blind clinical trial suggests that a daily 28 mg dose of Affron saffron extract may improve mood, sleep quality, and self-esteem in menopausal and post-menopausal women. Published in Frontiers in Nutrition, the research highlights a potential non-pharmaceutical intervention for the interconnected emotional challenges often experienced during this life stage.
Z Squared Inc. has named Jeffrey Harris as its new Chief Technology Officer, a strategic move that aligns with the company’s ongoing efforts to acquire a majority interest in Harris’s firm, Paradox Data LLC, as it pivots toward high-density AI-ready computing infrastructure.
Toronto-based energy developer PowerBank Corporation is raising $4.2 million through a registered direct offering of 7 million common shares. The capital infusion, set to close around July 1, 2026, aims to accelerate the company’s independent power producer portfolio and its current work with U.S. military and naval agencies.
Patients treated with Skyhawk Therapeutics’ oral therapy SKY-0515 showed no signs of Huntington’s disease progression over twelve months, according to interim data presented at the European Academy of Neurology. The findings indicate stabilization or improvement across all four clinical subcomponents of the disease, defying expected rates of functional and cognitive decline.
Samsung Biologics has accelerated its transition to renewable energy and expanded supply chain oversight, according to its 2026 ESG report released today. The Incheon-based CDMO increased its renewable energy usage to 39.8% while broadening the scope of its carbon emissions reporting to cover 63.7% of its value chain.
The U.S. Nuclear Regulatory Commission has granted a 20-year renewal of the Source Materials License for the Dewey Burdock project in South Dakota. This regulatory milestone completes the federal permitting process for the site, allowing enCore Energy to move forward with its plans for in-situ recovery uranium extraction.
With global commodity markets facing persistent instability, Geneva-based Mercuria Energy Trading has finalized a $3.84 billion multi-currency revolving credit facility. The syndication, which launched in April, drew significant interest from international lenders, ultimately exceeding the company’s initial target by $340 million despite a complex geopolitical climate.
Sixty percent of AI projects currently fail to reach deployment because they lack AI-ready data, a structural gap that defines the mission of BBI as the Schaumburg-based firm marks its tenth anniversary. Since 2016, the consultancy has focused on building the backend architecture required to support modern enterprise analytics.
Nearly 8 in 10 Americans believe the nation is focusing its innovative energy on the wrong areas, according to a recent survey from PMI U.S. The data suggests that public patience for corporate rhetoric is wearing thin, with a clear preference for tangible problem-solving over high-tech novelty.
Cryptocurrency exchange BingX has launched a partnership with Save the Children Hong Kong to bolster humanitarian efforts in the Western Balkans. The initiative targets children impacted by migration, extreme poverty, and social exclusion, marking the charity's first formal collaboration with a digital asset firm.
Fifty years after Alba and Lewis Ehrlich founded their modest plumbing shop in 1976, the family business is shedding its original moniker. Now rebranded as Test of Time Plumbing, Heating, Cooling & Electrical, the Boston-area firm is expanding its service footprint while keeping its third-generation leadership intact.
Nicholas T. Meserve will step into the role of CEO at MSC Income Fund in the fourth quarter of 2026, succeeding Dwayne L. Hyzak. The transition, part of a long-term board succession plan, will see Hyzak shift to the position of executive chairman to provide continued guidance.
Patients with Huntington’s disease treated with Skyhawk Therapeutics’ oral drug SKY-0515 showed no clinical worsening after twelve months, according to interim data from a Phase 1/2 trial. The findings, presented at the European Academy of Neurology, suggest the small molecule therapy may stabilize disease progression in early-stage participants.
With registration number 27 now officially granted by the Kanto Local Finance Bureau, Tokyo-based transcosmos is moving beyond standard outsourcing to handle direct financial transactions. The company plans to integrate digital touchpoints with back-office execution to support deposit, lending, and securities operations for its institutional clients.
Irvine-based My Office Apps is integrating direct store delivery capabilities directly into its Kechie ERP platform, allowing mobile field sales to sync instantly with warehouse and accounting databases. This update eliminates the need for manual reconciliation by treating delivery vehicles as active, tracked nodes within the company’s inventory ecosystem.
With a donation exceeding $14 million to children’s hospitals, 7-Eleven, Inc. is framing its 2025 business strategy around social responsibility. The Irving-based retailer’s latest impact report details a push to balance its massive convenience-store footprint with energy-efficient upgrades and reduced plastic waste across its private-brand packaging.
The global market for data center liquid-cooling manifolds is set for rapid expansion, projected to grow from $0.94 billion in 2026 to $6.33 billion by 2033. Driven by the intense thermal demands of AI training clusters and high-performance computing, the sector is expected to maintain a compound annual growth rate of 31.2%.
